• Trade with Confidence
    • CanninBot™
    • CanninPlus™
  • Investor Resources
    • News
    • Featured Companies
  • About
  • Login
0 Items
Cannin. com - Cannabis Stock Investing
  • Trade with Confidence
    • CanninBot™
    • CanninPlus™
  • Investor Resources
    • News
    • Featured Companies
  • About
Select Page
XXII Achieves “Holy Grail” of Cannabis Plant Science – Is XXII a Strong Buy?

XXII Achieves “Holy Grail” of Cannabis Plant Science – Is XXII a Strong Buy?

Cannabis in the News, Technology/Innovations

XXII Achieves “Holy Grail” of Cannabis Plant Science 22nd Century Group (XXII) just announced a breakthrough in its hemp/cannabis plant research leading to the successful transformation of the hemp/cannabis plant genome using a proprietary plant...
Lexaria Bioscience Pursuing Regulatory Approvals for DehydraTECH CBD

Lexaria Bioscience Pursuing Regulatory Approvals for DehydraTECH CBD

Cannabis in the News, Research, Science, Technology/Innovations

Lexaria Bioscience Pursuing Regulatory Approvals for DehydraTECH CBD Lexaria Bioscience Corp. (NASDAQ: LEXX) is embarking on new programs as well as extending ongoing ones as it pursues regulatory approvals and entry into different market sectors. Related: Should You...
Lexaria Bioscience CBD Study Results Expected to Demonstrate Effectiveness Against Hypertension

Lexaria Bioscience CBD Study Results Expected to Demonstrate Effectiveness Against Hypertension

Cannabis in the News, Science, Technology/Innovations

Lexaria Bioscience CBD Study Results Expected to Demonstrate Effectiveness Against Hypertension Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its human clinical study HYPER-H21-3 is expected to complete...
CURE Pharmaceutical: Should You Buy this Cannabis Biotech Stock?

CURE Pharmaceutical: Should You Buy this Cannabis Biotech Stock?

Cannabis in the News, CBD in the News, CBD Stocks, Finance, Investment Opportunities, marijuana stock, Research, Stock Talk, Technology/Innovations, Trending

Should you buy this cannabis biotech stock CURE Pharmaceutical? CURE Pharmaceutical Holding Corp. (OTC: CURR) focuses on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms (thin wafers and thin films). Notably,...
Psychedelic Stocks: Nova Mentis Files Genetic Disease Patent

Psychedelic Stocks: Nova Mentis Files Genetic Disease Patent

Cannabis in the News, Investment Opportunities, Psychedelic Stocks, Research, Technology/Innovations

Psychedelic Stocks: Nova Mentis Files Genetic Disease Patent Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based...
Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2

Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2

Cannabis in the News, CBD in the News, CBD Stocks, Investment Opportunities, marijuana stock, New Product, Research, Technology/Innovations

Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with Health Canada Consent — McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm...
« Older Entries

Already Registered,
Login below to add a listing

Login

 
 
Forgot Password

Search Cannabis and Hemp Stocks

Predict Price Movements of Stocks Before the Market Opens 4

Get Free Stock Alerts

* indicates required




Recent Posts

  • SNDL Q1 2022 Net Loss Narrows, Revenue Rises May 17, 2022
  • Top 20 Stock Movers During Tuesday’s Pre-market Trading May 17, 2022
  • TerrAscend launches first concentrates in New Jersey May 17, 2022
  • Nebraska medical marijuana petition drive sues to ease ballot rules May 17, 2022
  • SNDL Leads Cannabis Stocks Ahead of Today’s Earnings Call May 16, 2022

Predict Price Movements of Stocks Before the Market Opens 4

Search for Specific Hemp and Cannabis Stocks

From the Cannin Community

"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"

-Mark H.
Vail, Colorado

CanninPlus with Trading Alerts!

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$99 / month after 7-day trial. Still unsure? Schedule demo at [email protected] or call 720-254-1374

Risk of Prosecution for Marijuana-Related Companies.  If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution.  The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana.  Many states impose and enforce similar prohibitions.  Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”

  • Facebook
  • Twitter
  • Instagram
© 2020 Cannin All Rights Reserved. | Refund | Terms | Privacy | Cannin.com 3000 Lawrence Street #6 Denver, Colorado 80205